Literature DB >> 7140580

Synapse formation is related to the onset of neuron-specific enolase immunoreactivity in the avian auditory and vestibular systems.

M C Whitehead, P J Marangos, S M Connolly, D K Morest.   

Abstract

Neuron-specific enolase (NSE) is a unique form of the glycolytic enzyme, enolase, which, in the brain, is strictly localized in differentiated neurons and neuroendocrine cells. In this report evidence is presented that NSE is first seen in the cell bodies of developing chick auditory and vestibular neurons shortly after the time when they first form immature synapses. Subsequently, immunoreactive NSE increases and spreads into transiently appearing structures which participate in the morphogenesis of mature synaptic arrangements. These data correlate synaptogenesis with the differentiation of a specific neuronal enzyme.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7140580     DOI: 10.1159/000112689

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  4 in total

1.  Immunohistochemical studies on neuron-specific enolase in developing rat vallate papillae.

Authors:  K Hirata; T Kanaseki
Journal:  Anat Embryol (Berl)       Date:  1989

2.  Developmental changes in translatable mRNAs for the cerebral enolase isozymes alphaalpha and gammagamma.

Authors:  Y Zeitoun; N Lamandé; A Keller; F Gros; L Legault-Demare
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

Review 3.  The role of KATP channels in cerebral ischemic stroke and diabetes.

Authors:  Vivian Szeto; Nai-Hong Chen; Hong-Shuo Sun; Zhong-Ping Feng
Journal:  Acta Pharmacol Sin       Date:  2018-04-19       Impact factor: 6.150

4.  A Testosterone Metabolite 19-Hydroxyandrostenedione Induces Neuroendocrine Trans-Differentiation of Prostate Cancer Cells via an Ectopic Olfactory Receptor.

Authors:  Tatjana Abaffy; James R Bain; Michael J Muehlbauer; Ivan Spasojevic; Shweta Lodha; Elisa Bruguera; Sara K O'Neal; So Young Kim; Hiroaki Matsunami
Journal:  Front Oncol       Date:  2018-05-28       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.